Russian news in brief
- The authorities in Russia's Khabarovsk region have announced thatincreases in the prices of pharmaceuticals on the local market will now be regulated by the regional authorities, reports the RIA Novosti news agency. Regulation of drug prices has been introduced in order to prevent price fluctuations.
- A project to set up a drugs quality control laboratory in Russia has been agreed by Ideal Medical Products of France and the Russian MEDTECHSNAB enterprise.
The project will be funded jointly and will benefit from the contribution of 12 financial firms in the Russian Association for the Promotion of Quality Drugs (Apromediq) and the private-sector aid fund FASEP, set up through the French Economic and Finance Ministry.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze